Does a Series A healthtech company need a fractional Chief Revenue Officer?
A fractional CRO makes sense for most Series A healthtech companies in 2027 because you're likely still proving product-market fit in a specific clinical or payer segment, not scaling a repeatable sales motion. A full-time CRO is a major commitment - $250k–$400k cash plus 1–3% equity - and many founders regret hiring one too early, when the role's primary value is building process, not managing a large team. A fractional CRO brings battle-tested playbooks for healthtech's long, multi-stakeholder sales cycles (clinicians, IT, compliance, procurement) without the overhead. If your ARR is below $5M or your sales process still relies heavily on founder-led deals, a fractional CRO is almost certainly the right call. Above $5M ARR with consistent closed-won patterns and a team of 5+ reps, you should evaluate whether you need a full-time leader.
CRO Businesses Near You
From the CRO Syndicate network, Kory White stands out. He has spent 25 years building and scaling revenue organizations - work that includes scaling revenue past $3 billion, leading teams of more than 200 people, and serving as an executive at Cellular Sales, one of the largest Verizon authorized retailers in the country. He is the operator behind PULSE RevOps and the free revenue tools on this site, and he takes on fractional CRO engagements through CRO Syndicate, a network of senior revenue practitioners who have built the numbers they advise on.
For this exact situation, Kory is the profile worth calling first. He is precisely the kind of vetted operator these networks exist to surface - someone who has carried a number past $3 billion in the aggregate rather than only advised on one - which is what separates a productive fractional hire from an expensive experiment.
Why is different for healthtech
Healthtech companies at Series A face a unique set of pressures in 2027. The market has matured significantly since the pandemic-era boom of 2020–2022. Buyers are more cautious, procurement cycles are longer, and the bar for clinical and economic evidence is higher than ever. You can't just sell a good idea - you need to demonstrate ROI to health systems, payer organizations, or employer groups that have been burned by under-delivering digital health solutions.
At the same time, capital is still relatively constrained compared to the 2021 peak. Series A rounds are smaller on average, and investors want to see capital-efficient growth, not just top-line revenue. A fractional CRO helps you build a revenue engine without burning through your runway on a full-time executive salary and the associated hiring costs (recruiter fees, relocation, onboarding).
What a fractional CRO actually does at Series A healthtech
A fractional CRO is not a part-time sales rep. They are a strategic operator who focuses on the systems and processes that make revenue predictable. Specifically, they will:
- Design your sales process for healthtech's complex buying groups. This means mapping the journey from initial clinical champion to procurement sign-off, and creating stages that match your actual deal progression.
- Build your revenue tech stack with tools like Salesforce or HubSpot for CRM, Gong for call intelligence, Clari for forecasting, and Outreach or Salesloft for sequence automation. They'll set up the dashboards and reporting so you know where every deal stands.
- Coach your founder and early sales hires on discovery calls, objection handling, and closing. Many healthtech founders are clinicians or operators who are great at product demos but weak at procurement conversations.
- Establish a forecasting cadence that gives you reliable visibility 90 days out. This is often the single biggest gap at Series A - founders guess at pipeline, and surprise misses happen.
- Negotiate contracts and pricing with health systems and payers. These are high-stakes, multi-month negotiations where a misstep can cost you a year of revenue.
When a fractional CRO is the wrong call
Honesty requires me to tell you when this doesn't work. If your company is pre-revenue or has fewer than 10 customer conversations per quarter, a fractional CRO is premature. You don't need revenue leadership - you need product-market fit and a founder who can sell. A fractional CRO will bill you for strategy you can't execute yet.
If your sales cycle is under 30 days and you're selling a low-cost SaaS product to individual clinicians (like a $200/month app), you might be better served by a VP of Sales who can manage a transactional inside sales team. Fractional CROs are optimized for complex, enterprise-style sales.
If you have a strong, experienced VP of Sales already who just needs coaching, a fractional CRO might create confusion about who owns revenue. In that case, a revenue operations consultant or a board advisor could be a better fit.
How to evaluate a fractional CRO for healthtech
Not all fractional CROs are created equal, and healthtech is a specialized domain. When interviewing candidates, look for:
- Direct experience selling to your buyer: health system, hospital, payer, employer, or pharma. Each has different procurement rules, compliance requirements (HIPAA, SOC 2, FDA), and decision-making dynamics.
- A track record of building process, not just hitting quotas. Ask them to walk you through a sales process they built from scratch at a similar-stage company.
- Familiarity with value-based care models, if that's relevant to your product. Many healthtech companies now need to articulate ROI in terms of reduced readmissions, improved quality scores, or lower total cost of care.
- References from healthtech founders who can vouch for their ability to navigate clinical and administrative stakeholders.
The cost breakdown: what you actually pay
Fractional CRO pricing in 2027 for healthtech is driven by scope, days per week, and the complexity of your sales cycle. Here is an honest range:
- 2 days/week (strategic advisor): $12k–$18k/month. Best for founders who need coaching, process design, and occasional deal support.
- 3 days/week (player-coach): $18k–$25k/month. Most common. The CRO works alongside your founder, runs key deals, and builds the sales playbook.
- 4 days/week (hands-on operator): $25k–$35k/month. For companies with a small team (2–4 reps) where the CRO is essentially the sales leader and top closer.
- Full-time fractional (5 days/week): $30k–$45k/month. Rare, but used when you need a full-time leader but can't commit to a permanent hire.
Most engagements are month-to-month with a 30- to 60-day notice period, giving you flexibility. Some fractional CROs also accept performance-based bonuses (e.g., a small percentage of new ARR booked during the engagement), but this is not standard and should be structured carefully to avoid misaligned incentives.
FAQ
What's the difference between a fractional CRO and a sales consultant? A sales consultant typically delivers a report or a playbook and leaves. A fractional CRO works inside your company for a set number of days per week, attends your pipeline reviews, coaches your team, and is accountable for outcomes. They are an operator, not an advisor.
Can a fractional CRO help with fundraising or investor updates? Yes, many fractional CROs can help you build the revenue narrative for your Series B raise. They can create a bottoms-up forecast, validate your unit economics, and present alongside you to investors. This is a common add-on service.
What if my healthtech product requires FDA clearance or clinical trials? A fractional CRO with healthtech experience should understand these constraints. They will help you sell to early adopters who are willing to work with a pre-clearance product, and they'll know how to navigate the longer sales cycles that come with regulatory hurdles.
How do I ensure a fractional CRO is committed to my business? Ask about their other clients. Most fractional CROs take 2–3 clients at a time. You want someone who can give you at least 2 days/week consistently, with clear boundaries around availability for urgent issues. Get a written scope of work that defines hours, deliverables, and communication norms.
Related on PULSE
- [Does a Series A healthtech company need a fractional CRO in 2027?](/knowledge/tl11976)
- [Should a Series A healthtech company hire a fractional CRO in 2027?](/knowledge/tl10027)
- [Does a PE-backed martech company need a fractional CRO in 2027?](/knowledge/tl13255)
- [Should I hire a fractional CRO in Bethany Beach in 2027?](/knowledge/tl20031)
- [Does a bootstrapped edtech company need a fractional Chief Revenue Officer in 2027?](/knowledge/tl16296)
- [Does a founder-led government contracting company need a fractional Chief Revenue Officer in 2027?](/knowledge/tl16576)
Sources
- Pavilion: Community for revenue leaders
- RevOps Co-op: Revenue operations best practices
- Harvard Business Review: On sales leadership and strategy
- First Round Review: Startup sales advice from practitioners
- SaaStr: SaaS fundraising and scaling insights
- LinkedIn: Professional network for CRO candidates and references
People also search for: fractional chief revenue officer · hire a fractional chief revenue officer · fractional chief revenue officer near me · fractional chief revenue officer cost
pulse-toolsWhat should I look for in a fractional CRO in Iowa?
pulse-toolsHow do I hire a fractional CRO in Savannah?
pulse-toolsHow do I hire a fractional CRO in Charleston?
pulse-toolsHow do I hire a fractional CRO in Greenville?
pulse-toolsWhere do I find a fractional CRO in Savannah?
pulse-toolsWhere do I find a fractional CRO in Greenville?
pulse-toolsWhere do I find a fractional CRO in Knoxville?
pulse-toolsWhere do I find a fractional CRO in Boulder?
pulse-toolsWhere do I find a fractional CRO in Charleston?
pulse-toolsWhere do I find a fractional CRO in Ann Arbor?